Will Medicare Pay for Ozempic in 2026?

Direct Answer

It depends on the diagnosis on the prescription. Medicare Part D and Medicare Advantage drug plans pay for Ozempic when it treats type 2 diabetes, but Original Medicare never pays for it, and Part D still cannot pay for it when it is prescribed only for weight loss in 2026.

What Original Medicare Covers

Original Medicare splits into Medicare Part A, which pays for hospital stays, and Medicare Part B, which pays for doctor visits and outpatient medical services. Neither part pays for Ozempic because it is a self-injected prescription drug you take at home, not a hospital stay or an in-office medical service. Part B does cover a small set of physician-administered drugs given in a clinical setting, but Ozempic does not qualify because patients inject it themselves. A Medigap policy will not help either, since Medigap only fills cost-sharing gaps in Part A and Part B and never covers outpatient prescription drugs. Beneficiaries who rely only on Original Medicare need a separate Part D plan to get any Ozempic coverage at all.

What Medicare Part D Covers for Ozempic

Medicare Part D covers Ozempic (semaglutide) when a prescriber documents type 2 diabetes, and many plans also require evidence of reduced cardiovascular risk in patients with established heart disease. In 2026, 89% of Part D plans require prior authorization, meaning your prescriber must submit clinical notes, HbA1c lab values, and prior treatment history before the plan approves the drug. About 34% of plans also apply step therapy, requiring you to try a first-line medication like metformin or a sulfonylurea before the plan pays for a GLP-1 drug like Ozempic.

Federal law has never allowed Part D to cover Ozempic, Wegovy, or any drug when the sole indication on the prescription is weight loss, because the Medicare statute historically excludes agents used for weight loss from the Part D formulary. In April 2025, the Centers for Medicare and Medicaid Services declined to finalize a proposed rule that would have let Part D plans cover anti-obesity medications broadly starting in 2026, so that exclusion remains in place for the standard Part D benefit this year.

What Medicare Advantage May Add

Medicare Advantage plans that bundle drug coverage, known as MA-PD plans, follow the same federal rule as standalone Part D: Ozempic is covered for type 2 diabetes and excluded for weight-loss-only prescriptions in 2026. What varies plan by plan is the formulary tier Ozempic sits on, whether the plan requires prior authorization or step therapy on top of the federal minimum, and which pharmacies are in-network. Some MA-PD plans place Ozempic on a lower cost-sharing tier than standalone Part D plans do, so comparing formularies during Medicare Advantage Open Enrollment (January 1 to March 31, 2026) or the fall Annual Enrollment Period (October 15 to December 7, 2026) can lower your monthly cost even without changing the underlying coverage rule.

The Medicare GLP-1 Bridge Program: What It Does Not Include

The Medicare GLP-1 Bridge is a CMS demonstration running from July 1, 2026 through December 31, 2027 that lets eligible Part D enrollees get Wegovy or Zepbound for weight loss at a flat $50 monthly copay. Novo Nordisk and Eli Lilly agreed to supply these drugs to the program at a negotiated net price of about $245 per 30-day supply, far below list price. Eligibility requires active Part D enrollment, a qualifying body mass index, and prior authorization documenting a weight-management indication.

Ozempic is not one of the drugs in the Bridge program, so getting Wegovy or Zepbound covered under it does not change whether Medicare pays for your Ozempic prescription. A related, broader initiative called the BALANCE Model was expected to expand GLP-1 weight-loss coverage further in 2027, but CMS announced an indefinite delay to that model and extended the Bridge program through the end of 2027 instead. If your prescriber wants you specifically on Ozempic for weight management, ask about switching to Wegovy, which shares the same active ingredient (semaglutide) and is Bridge-eligible.

Cost of Ozempic Without Full Coverage (2026)

Ozempic carries a list price of about $969 to $1,030 per month in 2026 depending on the pharmacy and pen strength. If your Part D plan covers Ozempic for diabetes, your cost depends on where you sit in the 2026 Part D benefit design: plans can charge up to a $615 deductible, then coinsurance or a copay until you reach the $2,100 annual out-of-pocket cap set by the Inflation Reduction Act, after which the plan covers 100% of costs for the rest of the year. If your plan denies Ozempic because the prescription is for weight loss, Novo Nordisk's NovoCare Pharmacy cash-pay program sells Ozempic to self-pay patients for about $349 a month at the 0.25 mg, 0.5 mg, and 1 mg doses, and $499 a month at the 2 mg dose, with an introductory rate of $199 a month for the first two fills through December 31, 2026.

Alternatives If Medicare Will Not Pay for Your Ozempic

If Medicare denies Ozempic because your prescription is for weight loss rather than diabetes, three paths are worth checking. First, ask your prescriber whether switching to Wegovy makes you eligible for the $50-a-month Medicare GLP-1 Bridge program, since Wegovy contains the same active ingredient as Ozempic and is one of the drugs the Bridge covers. Second, compare the NovoCare Pharmacy cash-pay price against your local pharmacy's cash price using a discount card like GoodRx, since manufacturer direct pricing is often lower than an uninsured retail fill. Third, if you are not yet 65 and are comparing options before Medicare eligibility starts, an ACA-compliant marketplace plan must treat diabetes as a covered condition regardless of any preexisting condition, and prescription drugs are one of the ten essential health benefits every ACA-compliant plan must include, though formularies for weight-loss drugs still vary by insurer.

How to Find a Part D Plan That Covers Ozempic

Medicare.gov's Plan Finder tool lets you enter Ozempic by name and dose and see which Part D and Medicare Advantage plans in your area cover it, at what formulary tier, and whether prior authorization or step therapy applies before you enroll. Comparing plans during the Annual Enrollment Period (October 15 to December 7, 2026, for coverage starting January 1, 2027) is the most reliable way to lower your Ozempic cost, since formulary tier placement for the same drug can vary by hundreds of dollars a year between plans in the same ZIP code.

• Go to medicare.gov/plan-compare and enter your ZIP code and current medications, including Ozempic.
• Compare the formulary tier and estimated annual cost for Ozempic across each Part D and MA-PD plan shown.
• Check whether the plan requires prior authorization or step therapy before Ozempic is approved.
• Ask your prescriber to submit the prior authorization request as soon as your new plan year starts.

Does Original Medicare cover Ozempic?

No. Original Medicare Part A and Part B never pay for Ozempic because it is a self-injected drug you take at home, not a hospital or in-office medical service. You need a separate Medicare Part D plan or a Medicare Advantage plan with drug coverage to get any help paying for it.

Does Medicare Part D cover Ozempic for weight loss?

No, not in 2026. Federal law excludes drugs prescribed solely for weight loss from the standard Part D formulary. CMS declined to finalize a 2025 proposed rule that would have changed this for 2026, so Part D still only pays for Ozempic when the diagnosis on the prescription is type 2 diabetes.

Does Medicare Advantage cover Ozempic?

Yes, for type 2 diabetes. Medicare Advantage plans that include drug coverage (MA-PD plans) follow the same federal rule as standalone Part D: Ozempic is covered for diabetes and excluded for weight-loss-only prescriptions in 2026. Formulary tier, prior authorization, and step therapy rules vary by plan.

What is the Medicare GLP-1 Bridge program, and does it cover Ozempic?

The Medicare GLP-1 Bridge is a CMS demonstration running July 1, 2026 through December 31, 2027 that covers Wegovy and Zepbound for weight loss at a $50 monthly copay for eligible Part D enrollees. Ozempic is not one of the drugs included; only Wegovy and Zepbound qualify.

How much does Ozempic cost without Medicare coverage in 2026?

Ozempic's list price runs about $969 to $1,030 a month in 2026. Novo Nordisk's NovoCare Pharmacy cash-pay program lowers that to about $349 a month for the 0.25 mg, 0.5 mg, and 1 mg doses, with a $199-a-month introductory rate for a self-pay patient's first two fills through December 31, 2026.

What if my Medicare Part D plan denies my Ozempic prescription?

Ask your prescriber to submit prior authorization documentation, including HbA1c lab values and prior treatment history, since 89% of Part D plans require this for Ozempic. If your plan still denies coverage in writing, you have the right to appeal, and you can compare plan formularies during the next enrollment period if Ozempic is consistently denied.

Will Medicare cover Ozempic for weight loss in the future?

It is uncertain as of 2026. A broader initiative called the BALANCE Model was expected to expand GLP-1 weight-loss coverage in Medicare Part D and Medicaid starting in 2027, but CMS announced an indefinite delay to that model while extending the separate GLP-1 Bridge program (which covers Wegovy and Zepbound, not Ozempic) through the end of 2027.

What is the difference between Ozempic and Wegovy for Medicare coverage?

Ozempic and Wegovy both contain semaglutide, but they are FDA-approved for different uses: Ozempic for type 2 diabetes and Wegovy for chronic weight management. Because of that difference, Medicare Part D covers Ozempic for diabetes but does not cover it for weight loss, while Wegovy is eligible for the $50-a-month Medicare GLP-1 Bridge program for weight loss in 2026.